SIERRA ONCOLOGY, INC. Operating Cash Flow
SIERRA ONCOLOGY, INC. reported Operating Cash Flow of -$25.74 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-05-06
- SIERRA ONCOLOGY, INC. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$25.74M.
- SIERRA ONCOLOGY, INC. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$15.25M.
- SIERRA ONCOLOGY, INC. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$29.75M.
- SIERRA ONCOLOGY, INC. net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$17.00M.
- SIERRA ONCOLOGY, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$78.96M.
- SIERRA ONCOLOGY, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$52.37M.
- SIERRA ONCOLOGY, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$51.18M.
- SIERRA ONCOLOGY, INC. net cash provided by (used in) operating activities for fiscal 2018 was -$45.12M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$25.74M 10-Q · filed 2022-05-06 | -$40.99M derived: sum of 2 quarters · filed 2022-05-06 | -$70.73M derived: sum of 3 quarters · filed 2022-05-06 | -$87.74M derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-12-31 | -$15.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$45.00M derived: sum of 2 quarters · filed 2022-03-10 | -$62.00M derived: sum of 3 quarters · filed 2022-03-10 | -$78.96M 10-K · filed 2022-03-10 |
| 2021-09-30 | -$29.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$46.75M derived: sum of 2 quarters · filed 2021-11-05 | -$63.71M 10-Q · filed 2021-11-05 | -$76.46M derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-06-30 | -$17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$33.97M 10-Q · filed 2021-08-05 | -$46.71M derived: sum of 3 quarters · filed 2022-05-06 | -$62.11M derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-03-31 | -$16.96M 10-Q · filed 2022-05-06 | -$29.71M derived: sum of 2 quarters · filed 2022-05-06 | -$45.10M derived: sum of 3 quarters · filed 2022-05-06 | -$55.38M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | -$12.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$28.14M derived: sum of 2 quarters · filed 2022-03-10 | -$38.42M derived: sum of 3 quarters · filed 2022-03-10 | -$52.37M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$15.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$25.67M derived: sum of 2 quarters · filed 2021-11-05 | -$39.62M 10-Q · filed 2021-11-05 | -$52.07M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | -$10.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$24.23M 10-Q · filed 2021-08-05 | -$36.68M derived: sum of 3 quarters · filed 2022-03-10 | -$47.79M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | -$13.95M 10-Q · filed 2021-05-07 | -$26.40M derived: sum of 2 quarters · filed 2022-03-10 | -$37.51M derived: sum of 3 quarters · filed 2022-03-10 | -$49.56M derived: sum of 4 quarters · filed 2022-03-10 |
| 2019-12-31 | -$12.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$23.56M derived: sum of 2 quarters · filed 2022-03-10 | -$35.62M derived: sum of 3 quarters · filed 2022-03-10 | -$51.18M 10-K · filed 2022-03-10 |
| 2019-09-30 | -$11.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$23.16M derived: sum of 2 quarters · filed 2020-11-05 | -$38.73M 10-Q · filed 2020-11-05 | -$48.70M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | -$12.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$27.62M 10-Q · filed 2020-08-06 | -$37.59M derived: sum of 3 quarters · filed 2021-03-11 | -$51.86M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | -$15.57M 10-Q · filed 2020-05-07 | -$25.54M derived: sum of 2 quarters · filed 2021-03-11 | -$39.80M derived: sum of 3 quarters · filed 2021-03-11 | -$48.07M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | -$9.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$24.24M derived: sum of 2 quarters · filed 2021-03-11 | -$32.51M derived: sum of 3 quarters · filed 2021-03-11 | -$45.12M 10-K · filed 2021-03-11 |
| 2018-09-30 | -$14.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$22.53M derived: sum of 2 quarters · filed 2019-11-04 | -$35.14M 10-Q · filed 2019-11-04 | -$42.75M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-06-30 | -$8.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$20.88M 10-Q · filed 2019-08-08 | -$28.48M derived: sum of 3 quarters · filed 2020-03-03 | -$37.36M derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-03-31 | -$12.61M 10-Q · filed 2019-05-08 | -$20.22M derived: sum of 2 quarters · filed 2020-03-03 | -$29.09M derived: sum of 3 quarters · filed 2020-03-03 | |
| 2017-12-31 | -$7.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$16.48M derived: sum of 2 quarters · filed 2020-03-03 | -$36.16M 10-K · filed 2020-03-03 | |
| 2017-09-30 | -$8.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$28.55M 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$19.68M 10-Q · filed 2018-08-09 | |||
| 2016-12-31 | -$41.16M 10-K · filed 2019-02-28 |